Six Promising Healthcare Startups from Y Combinator’s Winter 2026 Demo Day File IPO Prospectuses

The latest season of YC Demo Day kicked off on March 22 and 23. Regarded as a key barometer for the venture capital industry, this event draws significant attention. From the 119 projects showcased at this winter’s Demo Day, VCBeat has selected six standout innovations in healthcare for your reference.

Y Combinator, a renowned U.S. startup incubator founded in 2005, was named the most valuable incubator by Forbes seven years later. To gauge just how impressive it is, look at the star companies it has incubated, as shown in the image below.


The latest cohort of companies invested in by Y Combinator, after three months of “boot camp,” will present their achievements at Demo Day to a carefully selected and invited audience.

1、Nurx -of the family planning communityUber

Obtaining prescription contraceptives in the United States is challenging, as it requires finding a suitable healthcare provider and engaging in consultations. Nurx positions itself as the most convenient platform for accessing prescription medications. Through Nurx’s web app, users can select their desired prescriptions. After an online consultation where a physician asks a series of questions typically covered in clinic visits, a prescription is issued. Within two hours, Nurx delivers the medication directly to your doorstep.
2、Stitch-Doctors'Slack

Information platforms are continuously revolutionizing across all industries. Stitch is a platform that provides healthcare information to doctors, nurses, social workers, pharmacists, and other professionals. Compliant with HIPAA standards, Stitch facilitates the creation of electronic health records. The company has already partnered with over 400 institutions and maintains a monthly growth rate of 40%. When asked about the secret to their growth, they attribute it to their strategic focus on nursing homes, rehabilitation facilities, pharmacies, and urgent care centers. Stitch boasts very high user engagement, with users spending an average of eight hours per day on the platform and sending 20 messages.

3、CareSkore-For Hospital Follow-up CareCRM

The U.S. Affordable Care Act stipulates that hospitals must bear the medical costs associated with avoidable patient readmissions resulting from inadequate follow-up care. Currently, patient readmissions impose an additional annual burden of $36 billion on hospitals. CareSkore assists hospitals in tracking each patient’s status accurately and in real time, enabling early detection of issues before patients’ conditions deteriorate. A demo of CareSkore has already helped hospitals reduce readmission rates by 42%. Its CRM product will be sold to hospitals at an annual price of $500,000, addressing a market opportunity valued at $10.8 billion per year.

4 Spinal Singularity–Better Catheters

According to statistics, more than 5 million people received catheter implants last year. Spinal Singularity aims to enter the $2 billion urinary catheter market by connecting its electromagnetic drive valve for controlling urine flow to catheters. This connected catheter is minimally invasive and can be inserted or removed at home. This year, Spinal Singularity is initiating clinical trials, with plans to begin direct-to-consumer sales next year.

5、HistoWiz–Histopathology in Cancer Research

Scientists are wasting time cutting tissue sections, while HistoWiz promises to save two weeks by allowing scientists to mail tissue samples and create a cloud database. Scientists believe that they can observe tissue sections online through instant access to remote virtual microscopes. The HistoWiz team is composed of cancer researchers and computer scientists. It has over 400 customers globally, with an annual net income of $1.2 million and growing at a rate of 300% per year.

Ke Chang, founder of HistoWiz, stated, “Until now, histological section data had not been consolidated in a single location. However, we already possess the largest database.”

 
6、iSono Health– Home Self-Testing Device for Breast Cancer

Currently, 8.6 million women are at risk of developing breast cancer. iSono Health aims to make breast screening more accessible for women. To this end, the company has developed a device that leverages wearable technology to perform automated, repetitive 3D ultrasound imaging. Free from radiation risks and requiring only two minutes, the device enables women to conduct monthly self-examinations and monitor changes from the comfort of their homes. iSono Health plans to launch the product next year, though its market price remains unclear at this stage.

About Y Combinator:

Y Combinator has pioneered a new investment model for early-stage startups: investing small amounts of capital in a large number of companies.

Each year, a large number of startup projects apply to participate in Y Combinator’s Demo Day, from which YC selects those that interest them. Startups whose projects are selected receive a $120,000 investment from YC in exchange for 7% equity in the company.

For entrepreneurs, being accepted into the Y Combinator (YC) incubator carries a distinctive prestige. It not only provides financial support but also offers extensive media exposure, thereby helping startups acquire their early seed users. Furthermore, during YC’s three-month training program, successful entrepreneurs and investors visit to share insights, giving founders the opportunity to engage closely with seasoned veterans who have achieved remarkable success in Silicon Valley, such as the CEO of Airbnb.